000059999 001__ 59999
000059999 005__ 20210121114521.0
000059999 0248_ $$2sideral$$a97744
000059999 037__ $$aART-2015-97744
000059999 041__ $$aeng
000059999 100__ $$aTreviño A
000059999 245__ $$aThe Burden of Neglected HIV-2 and HTLV-1 Infections in Spain.
000059999 260__ $$c2015
000059999 5060_ $$aAccess copy available to the general public$$fUnrestricted
000059999 5203_ $$aHIV-2  and  HTLV-1  infections  are  globally  less  frequent  than  those  produced  by  HIV-1,  the  classical  AIDS  
agent.  In  Spain  and  up  to  the  end  of  2014,  a  total  of  310  cases  of  HIV-2,  274  of  HTLV-1,  and  776  of  HTLV-2  
infections had been reported. No cases of HTLV-3 or HTLV-4 infections have been identified so far in Spain. 
Most  persons  infected  with  HIV-2  or  HTLV-1  acknowledge  epidemiological  risk  factors  for  contagion,  such  
as originating from or living in endemic regions and/or having had sexual partners from those areas. However, 
risk  factors  could  not  be  recognized  in  up  to  20-25%  of  carriers  in  Spain.  Thus,  it  seems  worth  keeping  a  
high level of clinical suspicion in order to identify earlier these neglected human retroviral infections, since 
diagnostic  procedures  and  antiviral  treatment  are  specific  for  each  of  these  agents.  In  this  article  we  
summarize  the  major  contributions  reported  at  the  meeting  of  the  Spanish  Group  for  HIV-2/HTLV  held  in  
Madrid in December 2014
000059999 536__ $$9info:eu-repo/grantAgreement/ES/FIS/AC15-00041$$9info:eu-repo/grantAgreement/ES/FIS/AC15-0003$$9info:eu-repo/grantAgreement/ES/FIS/CD14-0243$$9info:eu-repo/grantAgreement/ES/FIS/CES12-00$$9info:eu-repo/grantAgreement/ES/FIS/CM13-0309$$9info:eu-repo/grantAgreement/ES/FIS/FI14-0264$$9info:eu-repo/grantAgreement/ES/FIS/ICI14-00372$$9info:eu-repo/grantAgreement/ES/FIS/PI13-01574
000059999 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000059999 590__ $$a2.068$$b2015
000059999 591__ $$aINFECTIOUS DISEASES$$b52 / 83 = 0.627$$c2015$$dQ3$$eT2
000059999 591__ $$aIMMUNOLOGY$$b114 / 151 = 0.755$$c2015$$dQ4$$eT3
000059999 592__ $$a1.274$$b2015
000059999 593__ $$aInfectious Diseases$$c2015$$dQ1
000059999 593__ $$aPharmacology (medical)$$c2015$$dQ1
000059999 593__ $$aMedicine (miscellaneous)$$c2015$$dQ1
000059999 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000059999 700__ $$aCaballero E
000059999 700__ $$ade Mendoza C
000059999 700__ $$aAguilera A
000059999 700__ $$aPirón M
000059999 700__ $$aSoriano V
000059999 700__ $$aRodríguez M
000059999 700__ $$adel Romero J
000059999 700__ $$aMarcaida G
000059999 700__ $$aOcete MD
000059999 700__ $$aMolina I
000059999 700__ $$aAguilera A
000059999 700__ $$aRodríguez-Calviño JJ
000059999 700__ $$aNavarro D
000059999 700__ $$aRegueiro B
000059999 700__ $$0(orcid)0000-0001-5134-1006$$aBenito R$$uUniversidad de Zaragoza
000059999 700__ $$0(orcid)0000-0002-0036-6630$$aAlgarate S$$uUniversidad de Zaragoza
000059999 700__ $$0(orcid)0000-0002-2037-3213$$aGil J$$uUniversidad de Zaragoza
000059999 700__ $$aOrtiz de Lejarazu R
000059999 700__ $$aRojo S
000059999 700__ $$aEirós JM
000059999 700__ $$aManzardo C
000059999 700__ $$aMiró JM, García J
000059999 700__ $$aPaz I
000059999 700__ $$aPoveda E
000059999 700__ $$aCalderón E
000059999 700__ $$aMateos M
000059999 700__ $$aDronda F
000059999 700__ $$aEscudero D
000059999 700__ $$aTrigo M
000059999 700__ $$aDiz J
000059999 700__ $$aGarcía-Campello M
000059999 700__ $$aRodríguez-Iglesias M
000059999 700__ $$aHernández-Betancor A
000059999 700__ $$aMartín AM
000059999 700__ $$aRamos JM
000059999 700__ $$aGimeno A
000059999 700__ $$aGutiérrez F
000059999 700__ $$aRodríguez JC
000059999 700__ $$aSanchez V
000059999 700__ $$aGómez-Hernando C
000059999 700__ $$aCilla G
000059999 700__ $$aPérez-Trallero E
000059999 700__ $$aLópez-Aldeguer J
000059999 700__ $$aFernández-Pereira L
000059999 700__ $$aNiubó J
000059999 700__ $$aHernández M
000059999 700__ $$aLópez-Lirola AM
000059999 700__ $$aGómez-Sirvent JL
000059999 700__ $$aForce L
000059999 700__ $$aCifuentes C
000059999 700__ $$aPérez S
000059999 700__ $$aMorano L
000059999 700__ $$aRaya C
000059999 700__ $$aGonzález-Praetorius A
000059999 700__ $$aPérez JL
000059999 700__ $$aPeñaranda M
000059999 700__ $$aHernáez-Crespo S
000059999 700__ $$aMontejo JM
000059999 700__ $$aRoc L
000059999 700__ $$aMartínez-Sapiña A
000059999 700__ $$aViciana I
000059999 700__ $$aCabezas T
000059999 700__ $$aLozano A
000059999 700__ $$aFernández JM
000059999 700__ $$aGarcía-Bermejo I
000059999 700__ $$aGaspar G
000059999 700__ $$aGarcía R
000059999 700__ $$aGórgolas M
000059999 700__ $$aVegas MC
000059999 700__ $$aVegas C
000059999 700__ $$aBlas J
000059999 700__ $$aMiralles P
000059999 700__ $$aAldamiz T
000059999 700__ $$aMargall N
000059999 700__ $$aGuardia C
000059999 700__ $$aDo Pico E
000059999 700__ $$aPolo I
000059999 700__ $$aAguinaga A
000059999 700__ $$aEzpeleta C
000059999 700__ $$aSauleda S
000059999 700__ $$aTorres P
000059999 700__ $$aJiménez A
000059999 700__ $$aBlanco L
000059999 700__ $$aGonzález R
000059999 700__ $$aSuárez A
000059999 700__ $$aRequena S
000059999 700__ $$aBenítez-Gutiérrez L
000059999 700__ $$aCuervas-Mons V
000059999 700__ $$aBarreiro P
000059999 7102_ $$11008$$2630$$aUniversidad de Zaragoza$$bDpto. Microb.Med.Pr.,Sal.Públ.$$cÁrea Microbiología
000059999 773__ $$g17, 4 (2015), 212-219$$pAIDS rev.$$tAIDS REVIEWS$$x1139-6121
000059999 8564_ $$s257764$$uhttps://zaguan.unizar.es/record/59999/files/texto_completo.pdf$$yVersión publicada
000059999 8564_ $$s96521$$uhttps://zaguan.unizar.es/record/59999/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000059999 909CO $$ooai:zaguan.unizar.es:59999$$particulos$$pdriver
000059999 951__ $$a2021-01-21-11:03:30
000059999 980__ $$aARTICLE